Atlas Trials

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

Clinical trial NCT00274313 · COMPLETED

Trial details

NCT number
NCT00274313
Sponsor
Parion Sciences
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2006-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.